ArticleCureus2026
Strategic Analysis of the Robotic Surgery Market.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic-assisted surgery represents a rapidly growing segment of the US medical device market. This editorial applies Porter's Five Forces, political, economic, social, and technological (PEST) analysis, and value, rarity, inimitability, and organization (VRIO) analysis, along with qualitative interpretation, to examine the competitive structure of the robotic surgery market. High development costs, extensive healthcare regulation, and limited technological supply have slowed competitive entry, but growing demand has intensified competitive pressure. The market appears to favor established firms because of high switching costs, existing long-term hospital relationships, and surgical familiarity with established robotic platforms. Existing firms may be positioned for continued growth given these structural advantages; however, long-term success depends on their ability to scale efficiently, strengthen hospital relationships, and deliver value in an increasingly competitive, capital-intensive, and innovation-driven environment. Building on these findings, this analysis offers differentiated strategic implications for incumbents seeking to defend market position, established rivals pursuing growth, and well-capitalized entrants identifying viable points of entry into this complex market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.